Mission

Dafra Pharma International has dedicated its activities towards the health and wellbeing of the patients in Africa. Its mission is to continuously identify and develop new and improved treatments against malaria and other neglected tropical diseases.

Dafra Pharma International also endeavours to provide high quality branded generics and healthcare products to the African patient at affordable prices for it beliefs that high quality medications and health care products must be at the reach of every patient.

With its variety of first class medications, Dafra Pharma International wants to create an added value for patients, partners and investors. Its aim is to offer the first choice treatment.

History

Dafra Pharma International was incorporated in 1996 and started its activities in 1997. It is a private family owned Belgian pharmaceutical company, established by Mr. Bruno Jansen (CEO) in close collaboration with his father, Dr Frans Herwig Jansen. The headquarters are located in Turnhout, Belgium. While Dr Frans Herwig Jansen and his R&D team were responsible for the continuous research and development of new antimalarial treatments based on artemisinin derivatives, hereby strictly following the recommendations of the WHO, Bruno Jansen created a very successful distribution and promotion network in Africa in order to introduce the new antimalarial medications in the African market and in a few Asian and South American countries.

The continuous growth of this unique African medical distribution network would not have been possible without the energetic engagement and loyalty of the African regional and countrymanagers.

In 1998 Ousmane Macinanke joined Dafra Pharma International and in 2000 he became the head of Dafra Promotion Afrique (DPA), at that time in Ivory Coast. Nowadays DPA is located in Mali (Bamako). This African office was and is responsible for the registration, promotion, marketing of Dafra Pharma International’s antimalarial medications in most of the French speaking African countires.

In 2001 Dafra Pharmaceuticals Ltd was established in Johannesburg, Pretoria having the responsibility for the registration, promotion, marketing and sales of Dafra Pharma International’s antimalarial medications in most English speaking African countries.

In order to improve service levels in Africa, Dafra Pharma International has established local representative offices in Nigeria, Kenya and the Democratic Republic of Congo since 2005.

In 2006, the African subsidiaries became fully licensed pharmaceutical companies.

Sourcing and distribution of pharmaceutical raw materials from Asia has been allocated to Dafra Hong Kong Ltd since 2006.

In 2007 Dafra Pharma International was established to regroup all the different Dafra Pharma companies worldwide under one holding.

Products

Dafra Pharma International aims for highest quality medication at affordable prices for a continent with limited purchasing capacity.

All the products of Dafra Pharma International meet the standards of the most recent Pharmacopeia (International and European) and are produced by European GMP manufacturers.

Special attention is given to the packaging of Dafra Pharma International’s products for distribution in developing countries with specific climate conditions (extreme high temperatures and humidity).

Research & Development

Dafra Pharma International has identified Research & Development as one of the most critical areas leading to a company’s success. The need for independent operations necessitated the creation of a separate entity within the Dafra Pharma International Holding:

Dafra Pharma International Research & Development bvba.

Apart from employing highly qualified scientific staff, joint ventures and partnerships have been set up with several universities, centres for research in Tropical Medicine and contract research centres.

This enables Dafra Pharma International to stay at the forefront of the new developments and to discover and develop new chemical entities in the fields of malaria and other neglected diseases.

Promotional Network

Dafra Pharma International has established several local representative offices and three local African pharmaceutical subsidiaries in order to improve service levels in Africa.

Over the last ten years, Dafra Pharma International’s unique promotional, marketing and distribution network has been enlarged up till about 130 African medical representatives. This network is implanted in more than 30 African countries.

They ensure a constant presence and proximity to the patient, prescribers, health professionals, hospitals, ministries of health, etc. Their presence is reinforced by coordinators who are responsible for the promotion and marketing policy in different regional areas of Africa or at country level. All the medical representatives of Dafra Pharma International are highly educated and well trained men and women. Correct didactic scientific information for prescription drugs is crucial for any health professional or prescriber. Therefore the medical representatives of Dafra Pharma International receive continuous training and formation. Presence of Dafra Pharma International in Africa :

Angola Kenya Benin Madagascar Botswana Malawi Burkina Faso Mali Burundi Mauretania Cameroon Mozambique Central African Republic Niger Chad Nigeria Congo (Brazzaville) Rwanda Democratic Republic of Congo Senegal Equatorial Guinea Sierra Leone Ethiopia Sudan Gabon Tanzania Gambia Togo Ghana Uganda Guinea Zambia Côte d’Ivoire Zimbabwe

Presence of Dafra Pharma International in other markets than Africa:

Financial Profile

Worldwide Dafra Pharma International is exporting to 37 countries!

Dafra Pharma International has seen a continuous growth in staff and professional collaborators. About 130 medical representatives are currently (2007) employed throughout the African continent and about 28 staff members in Belgium.

Over the last five years, the Dafra Pharma group of companies’ annual turnover has shown impressive growth. Expectations are that this will continue over the next decade, as Dafra Pharma International is opening up its unique African distribution and promotion network for the sale of branded generics medicines and a series of consumer healthcare products.